Loading organizations...
Loading organizations...
Oncology therapeutics development for cancer treatment.
Avenzo Therapeutics has raised $406.5M across 3 funding rounds.
Avenzo Therapeutics has raised $406.5M in total across 3 funding rounds.
Avenzo Therapeutics has raised $406.5M in total across 3 funding rounds.
Avenzo Therapeutics's investors include OrbiMed, SR One, Foresite Capital, Lilly Asia Ventures, Deep Track Capital, Delos Capital, INCE Capital, Longwood Fund, New Enterprise Associates, Quan Capital, Sands Capital, Sofinnova Ventures.
Avenzo Therapeutics has raised $406.5M across 3 funding rounds. Most recently, it raised $60.0M Series B in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 22, 2025 | $60.0M Series B | OrbiMed, SR One | Foresite Capital, Lilly Asia Ventures, Deep Track Capital, Delos Capital, INCE Capital, Longwood Fund, New Enterprise Associates, Quan Capital, Sands Capital, Sofinnova Ventures, Surveyor Capital, TF Capital |
| Mar 26, 2024 | $150.0M Series A | Jakob Dupont, Deep Track Capital, New Enterprise Associates, Sands Capital | Foresite Capital, Judith Li, Carl Gordon, Delos Capital, INCE Capital, Quan Capital, TF Capital |
| May 25, 2023 | $196.5M Other Equity |